Previous 10 | Next 10 |
– Patient dosing expected to begin mid-to-late Q1 2024 – CHARLESTOWN, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it ...
2024-01-12 08:14:44 ET More on Solid Biosciences Solid Biosciences raises $109M through private placement Solid Biosciences receives FDA Fast Track designation for Duchenne gene therapy candidate Seeking Alpha’s Quant Rating on Solid Biosciences Histor...
2024-01-09 12:43:25 ET Gainers: Neximmune NEXI +96% . Sentage Holdings SNTG +58% . Mountain Crest Acquisition Corp IV MCAF +48% . Zoomcar Holdings ZCAR +42% . Cutera CUTR +37% . Adicet Bio ( ACET ) +33% . Solid Biosciences ( SLDB ...
2024-01-08 11:36:08 ET DENVER, Colo., Jan. 8, 2023 ( www.247marketnews.com )- Solid Biosciences Inc. (NASDAQ: SLDB) stated, this morning, that it entered into a securities purchase agreement with a select group of institutional accredited investors to sell 16,973,103 shares of common st...
2024-01-08 07:30:07 ET Solid Biosciences ( NASDAQ: SLDB ) has entered into private placement to sell 16,973,103 shares of common stock at a price of $5.53 per share and, in lieu of common stock, pre-funded warrants to purchase up to 2,712,478 shares of common stock at a price...
CHARLESTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities purchase agreement with a select group of insti...
CHARLESTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the J...
2023-12-15 17:03:39 ET Gainers: Loop Industries ( LOOP ) +6% . Cognyte Software ( CGNT ) +5% . Generation ( GBIO ) +5% . Northern Technologies International Corporation ( NTIC ) +5% . Arcturus Therapeutics Holdings ( ARCT ...
2023-12-08 08:27:04 ET More on pr-market losers $ stocks. Aditxt appoints Ernie Lee as CEO of its wholly-owned subsidiary, Pearsanta IPO Roundup: WeBuy Global, Maison Solutions and more Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earn...
2023-12-07 17:09:39 ET Gainers: Grayscale Solana Trust ( OTCQB:GSOL ) +7% . Accolade ( ACCD ) +5% . TPI Composites ( TPIC ) +5% . Travere Therapeutics ( TVTX ) +4% . 1-800-FLOWERS ( FLWS ) +3% . Losers: HashiCorp ( HCP ...
News, Short Squeeze, Breakout and More Instantly...
Solid Biosciences Inc. Company Name:
SLDB Stock Symbol:
NASDAQ Market:
Solid Biosciences Inc. Website:
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“...
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that the Company has been added to the broad-market Russell 3000 ® Index as ...
2024-06-21 08:15:07 ET Piper Sandler analyst issues OVERWEIGHT recommendation for SLDB on June 21, 2024 06:49AM ET. The previous analyst recommendation was Overweight. SLDB was trading at $6.3 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...